SSG Insights | Week of November 11th, 2022
Quiet Quitting: Employee Engagement Issues in Disguise
The term “quiet quitting” swept the corporate world this summer, leading to debates over what it meant and if it mattered. Quiet quitting is described as employees performing the basic requirements of their jobs and nothing more. HR leaders can take proactive steps to engage their teams.
December 27 Due Date for Prescription Drug Cost Reporting is Approaching
As part of the Consolidated Appropriations Act of 2021 (CAA), group health plans and carriers will soon be required to report certain demographic and spending information about a plan’s prescription drug expenditures. The pharmacy reporting requirement generally applies to group health plans (both fully insured and self-insured) and carriers.
October 2022 | SSG Compliance Recap
In this Issue:
- IRS Announces Increased Limits for Certain Employee Benefits, Higher Fines for ACA Reporting Failures
- ACA Reporting Forms and Draft Instructions Available with Limited Changes for 2022
- Final Rule Resolves “Family Glitch” for ACA Marketplace Coverage
- December 27 Due Date for Prescription Drug Cost Reporting is Approaching
- Question of the Month
EMPLOYER WEBINAR
Year-End Compliance Reminders and a Look Ahead to 2023
Gain insights into 2023 and review final 2022 compliance requirements:
- Contraceptive coverage requirements and reproductive healthcare
- Prescription drug and healthcare reporting
- Critical adjusted benefit limits
Be able to answer these questions:
- What are upcoming employer responsibilities for coverage transparency?
- How are increased limits and higher fines for ACA reporting failures affecting employer and employee costs and risks?
- What legislative and litigation issues may impact employers in 2023?
Prev
